6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Transition from Pediatric to Adult Healthcare: Assessment of Specific Needs of Patients with Chronic Endocrine Conditions

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background/Aim: Transition from pediatric to adult care is a challenging turning point. The aim was to evaluate the transition process and needs expressed by patients with chronic endocrine conditions at transition in order to ensure program optimization. Methods: Prospective assessment of the transition period was conducted through completion of standardized questionnaires given to targeted patients. Two types were created: (1) a general questionnaire (GQ) addressing universal aspects of transition, and (2) a specific questionnaire (SQ) exploring concerns related to each endocrine condition. Three endocrinopathies (congenital adrenal hyperplasia, hypogonadotropic hypogonadism and growth hormone deficiency) were selected for assessment since they present specific challenges requiring characterization. Results: Over the last decade, 244 patients in transition were registered in our department and 153 were included since they presented one of the endocrinopathies selected. A total of 73 subjects completed both the GQ and the SQ. Over 80% of the patients were satisfied with the transition process in terms of organization, accessibility and medical care. The actual age of transition corresponded for most to the age considered by patients as ideal for transition. SQs identified psychosexual issues that must be addressed more systematically. Conclusion: This study identified key elements allowing the creation of an improved transition program tailored for our center and for each endocrine condition studied.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

          P C White (2000)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Effects of Interventions to Promote Self-Determination for Individuals With Disabilities

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transition to adult services for young people with disabilities: current evidence to guide future research.

              This article outlines the evidence upon which best practice guidelines for transition to adulthood for young people with physical and developmental disabilities were developed in Ontario, Canada, through consensus activities. Evidence was gathered from published and unpublished literature and focus groups with young people, parents, community members, service providers and policy makers across the province. The evidence was then synthesized and analyzed by an expert panel. Guidelines were developed in the areas of collaboration, capacity-building, information, education, and research. This article focuses on the findings of this project as they relate to transition services and care. These best practice guidelines for the transition to adulthood for young people with disabilities offer a starting point to encourage service providers to work collaboratively with young people, parents, communities, governments, and researchers. The evidence from this project supports a move away from purely service-driven models of transition to holistic, lifecourse/lifespan approaches. Recommendations for future study and collaborative knowledge dissemination are provided.
                Bookmark

                Author and article information

                Journal
                HRP
                Horm Res Paediatr
                10.1159/issn.1663-2818
                Hormone Research in Paediatrics
                S. Karger AG
                1663-2818
                1663-2826
                2012
                November 2012
                02 November 2012
                : 78
                : 4
                : 247-255
                Affiliations
                aEndocrinology Division, Department of Medicine, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR-CHUM), Montreal, Que., Canada; bDepartment of Endocrinology and Reproductive Medicine, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Pierre and Marie Curie University, cDepartment of Pediatric Endocrinology, Gynecology and Diabetology, AP-HP Hôpital Necker-Enfants Malades, Université Paris Descartes, and dCentre des Maladies Endocriniennes Rares de la Croissance, Paris, France
                Author notes
                *Prof. Philippe Touraine, Department of Endocrinology and Reproductive Medicine, AP-HP Groupe Hospitalier Pitié-Salpêtrière, 47–83, Boulevard de l’Hôpital, FR–75651 Paris Cedex 13 (France), E-Mail philippe.touraine@psl.aphp.fr
                Article
                343818 Horm Res Paediatr 2012;78:247–255
                10.1159/000343818
                23128858
                47345cc0-3bfd-4e13-9b9a-f88e05516a72
                © 2012 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 27 July 2012
                : 18 September 2012
                Page count
                Figures: 2, Tables: 3, Pages: 9
                Categories
                Original Paper

                Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
                Growth hormone deficiency,Congenital adrenal hyperplasia,Hypogonadotropic hypogonadism,Adolescents,Transition

                Comments

                Comment on this article